ORGO - Organogenesis Holdings Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
463,935
450,893
468,059
338,298
260,981
Cost of revenue
110,506
105,019
114,199
87,319
75,948
Gross profit
353,429
345,874
353,860
250,979
185,033
Operating expenses
Research development
36,627
39,762
30,742
20,086
14,799
Selling general and administrative
282,765
283,808
250,200
203,478
199,693
Total operating expenses
319,392
323,570
280,942
223,564
214,492
Operating income or loss
34,037
22,304
72,918
27,415
-29,459
Interest expense
2,892
2,009
7,236
11,279
8,996
Total other income/expenses net
-28
-13
-1,896
2,343
-1,849
Income before tax
31,117
20,282
63,786
18,479
-40,304
Income tax expense
-28,624
4,750
-31,116
530
150
Income from continuing operations
59,741
15,532
94,902
17,949
-40,454
Net income
59,741
15,532
94,902
17,949
-40,454
Net income available to common shareholders
59,741
15,532
94,902
17,949
-41,099
Basic EPS
-
0.12
0.73
0.16
-0.42
Diluted EPS
-
0.12
0.70
0.15
-0.42
Basic average shares
-
130,070
128,331
107,738
92,840
Diluted average shares
-
132,383
133,663
111,361
92,840
EBITDA
-
40,322
87,698
37,226
-21,877